VIVALIS

Hazard statements (CLP)

H317, H319, H335, H361f, H400, H410, H411

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Hazardous Ingredients

• Prothioconazole • Isoflucypram • N,N-Dimethyl decanamide

Hazard statements

H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H361f Suspected of damaging fertility. H410 Very toxic to aquatic life with long lasting effects. EUH401 To avoid risks to human health and the environment, comply with the instructions for use.

Precautionary statements

P201 Obtain special instructions before use. P261 Avoid breathing mist/ vapours. P280 Wear protective gloves/protective clothing/eye protection/face protection. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor/ physician. P391 Collect spillage. P410 Protect from sunlight. P501 Dispose of contents/container to a licensed hazardous-waste disposal contractor or collection site except for empty clean containers which can be disposed of as non- hazardous waste.

2.3 Other hazards

No additional hazards known beside those mentioned. Isoflucypram: This substance is not considered to be persistent, bioaccumulative and toxic (PBT). This substance is not considered to be very persistent and very bioaccumulative (vPvB). Prothioconazole: This substance is not considered to be persistent, bioaccumulative and toxic (PBT). This substance is not considered to be very persistent and very bioaccumulative (vPvB). N,N-Dimethyldecanamide: This substance is not considered to be persistent, bioaccumulative and toxic (PBT). This substance is not considered to be very persistent and very bioaccumulative (vPvB).

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Classification in accordance with Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures, as amended. Eye irritation: Category 2 H319 Causes serious eye irritation. Specific target organ toxicity - single exposure: Category 3 H335 May cause respiratory irritation. Skin sensitisation: Category 1B H317 May cause an allergic skin reaction. Reproductive toxicity: Category 2 H361f Suspected of damaging fertility. Short-term (acute) aquatic hazard: Category 1 H400 Very toxic to aquatic life. Long-term (chronic) aquatic hazard: Category 2 H411 Toxic to aquatic life with long lasting effects.